21. October 2013
New products, new catalogue, new prices! - Transglutaminase newsletter 4-2013
Document

14. October 2013
Press release: Structure of active coagulation factor XIII published
Document

25. September 2013
Structure of active Factor XIII (FXIIIa) published in Angewandte Chemie
Document

22. August 2013
Summer vacation is over - Transglutaminase Newsletter 3-2013
Document

13. May 2013
Isopeptidase App note - Transglutaminase Newsletter 2-2013
Document

11. April 2013
Zedira publication on inhibition of coagulation factor XIIIa from different animal species in Thromb. Res., March 2013
Document

28. March 2013
ZediXclusive Microbial Transglutaminase Assay Kit - Product Information
Document

18. February 2013
tTG detection with increased sensitivity! - Transglutaminase Newsletter 1-2013
Document

01. February 2013
Meet Zedira at the 57th Annual Meeting of Thrombosis and Haemostasis Research (Gesellschaft für Thrombose- und Hämostaseforschung, GTH) in Munich, Germany (February 20th - 23rd 2013). Please contact us via e-mail to make an appointment.
Document

09. January 2013
Zedira co-authors publication on Transglutaminase 6 in Amino Acids, January 2013
Document

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • Zedira publication: Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin
  • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
  • Press Release: Dr. Falk Pharma GmbH and Zedira enter a phase 1b clinical trial for a celiac disease drug
  • Zedira publication: Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope
  • Press release: Additional subsidy funding for clinical development of a celiac disease drug
  • Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
  • Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
  • Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
  • Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation

Blog  

Events  

  • MEDICA

    13.11.2017 - 16.11.2017
    Düsseldorf, Germany

  • Gordon Research Conference on: Transglutaminases in Human Disease Processes

    16.06.2018 - 17.06.2018
    Les Diablerets, Switzerland